-
Evaluation and Validation of the Hypoparathyroidism Daily Diary of Symptom Experience (HPT-DD-SE) and the Hypoparathyroidism Life Impact Questionnaire (HPT-LIQ)
Sep 9, 2025, 16:22 PM -
Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons
Sep 9, 2025, 16:22 PM -
A Description of the Incidence and Burden of Hyperkalemia in Irish Hospitals 2022-2024
Sep 9, 2025, 16:22 PM -
The Burden of Cognitive Impairment Associated With Schizophrenia (CIAS) on People With Lived Experience (PWLE): A National Canadian Survey
Sep 9, 2025, 16:22 PM -
Real-World Utilization Patterns of Corticosteroids in Ulcerative Colitis: Prevalence of Excessive Use in Routine Clinical Practice
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Generalizing the Lp(a) Dosing in Secondary Prevention in a Population of French Patients With Cardiovascular Disease
Sep 9, 2025, 16:22 PM -
Evaluating the Feasibility and Acceptability of a Personalized Endpoint: A Prospective Mixed Methods Study of Inventory-Facilitated Goal Attainment Scaling
Sep 9, 2025, 16:22 PM -
Prevalence of Obesity and Comorbidities Among People With Obesity in China, Japan, and EU5
Sep 9, 2025, 16:22 PM -
A Cost-Minimization and Budget Impact Analysis of NT-proBNP Screening for Systematic Sclerosis-Related Pulmonary Arterial Hypertension in an Australian Healthcare Setting
Sep 9, 2025, 16:22 PM -
Quantification of Life-Cycle Value Using Early Modeling to Support RD and Strategy Decisions: A Case Study of a Polymeric Heart Valve
Sep 9, 2025, 16:22 PM -
Data-Driven Alerts to Support the Care of People Living With Epilepsy and Provide an Infrastructure for the Development of Real-World Evidence
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in France, Italy, Spain, and Germany
Sep 9, 2025, 16:22 PM -
Annual Change in Türkiye’s Reimbursement List: A Comparative Descriptive Analysis of the 2023 and 2024 SUT Annex 4-A Lists
Sep 9, 2025, 16:22 PM -
What Does the New ILAP Refresh Mean for Pharmaceutical Development and Patient Access in the UK?
Sep 9, 2025, 16:22 PM -
Analysis of Pooled Real-World Utilization and Outcomes Data of rVIII-Single Chain Compared With Standard and Extended Half-Life FVIII Products for Prophylaxis of Hemophilia A in France, Germany, and Italy
Sep 9, 2025, 16:22 PM -
Modeled Number and Cost of Biparametric Magnetic Resonance Imaging (bpMRI) Examinations in a Nationwide Prostate Cancer Screening Program: Utilizing the Results of the Czech Prostapilot Study
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Colorectal Cancer Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Quality of Systematic Reviews With Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale
Sep 9, 2025, 16:22 PM -
Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology
Sep 9, 2025, 16:22 PM -
Looking Back to Go Forward: Reintegrating Scientific Considerations Into eCOA Design and Implementation
Sep 9, 2025, 16:22 PM
